Cannabis, known as the “plant of the thousand and one molecules1,” constantly offers us fresh chances for research. The potential applications of the rare cannabinoid CBT were regrettably neglected until recently, despite the fact that it is not the most recent discovery in the realm of cannabis.
It’s becoming conceivable to envision a world in which even the rarest cannabinoids are ubiquitous thanks to the most recent developments in cannabis science. Learn what CBT is in this tutorial, and discover why you need to monitor the CBT hemp industry’s quick development.
A uncommon, naturally occurring hemp cannabinoid called CBT cannabicitran was initially identified in 19742. Since 2019, CBN has been the main objective of research and development activities. ³ In fact, leading companies are presently working on a range of CBT products that, if successfully developed, may completely transform the hemp sector by reliably revealing its special advantages.
There are many different subtypes of CBT, and there are a variety of possible effects that this cannabinoid may have on the human body. However, CBT appears to be non-intoxicating, similar to CBD and CBG, and its potential advantages are substantial enough to merit considerable interest from the international scientific community.
Current CBT research is incredibly scarce. In 2011, Japanese scientists discovered a molecule from the Chinese rhododendron, a plant widely used in Traditional Chinese Medicine, that was chemically identical to CBT4 (TCM). One may contend that TCM practitioners have been employing CBT for centuries, giving current CBT study validity.
Then, a thorough study from 2018 that was published in Natural Product Communications5 gave more context for the history of CBT in cannabis. Cannabichromene (CBC)6, an unstable cannabinoid that is easily changed by enzymatic processes, is the source of CBT in cannabis, not CBGa, which raises new questions about the metabolism of cannabis flower throughout maturation.
The outcomes of the CBT research are keenly anticipated by the scientific community. We are just beginning to understand the special properties of this rare cannabinoid, and what we have discovered so far has the potential to completely alter the worldwide cannabis market.
CBT now appeals primarily to intrepid cannabis users who are constantly eager to try the latest and greatest. How this cannabinoid affects the human body and mind is still somewhat of a scientific mystery, but supporters of CBD and CBG are constantly anxious to explore new, non-psychoactive cannabinoids that may bestow special advantages not present in other hemp components.
Based on scant anecdotal evidence, CBT appears to produce non-intoxicating benefits that substantially mimic those provided by CBD, CBG, or any other hemp cannabinoid without the intoxicating effects. There isn’t enough anecdotal evidence to make any clear judgments about how CBT will effect people on an individual basis because it’s one of the least known and used cannabis drugs.
Since it aids in the resistance of chemicals like CBD to reverting to their natural crystalline states, CBT is already occasionally employed as an anti-crystallization component in the cannabis industry. CBT is a hemp substance that can be used to identify cannabinoids in a sample since it shares the same chemical connection with CBD as CBD does with THC.
According to a 1984 study6, CBT may offer glaucoma sufferers who now use THC an alternative to intoxicating cannabis that doesn’t get them high. Given the distinctive way CBT develops within the cannabis flower, we might anticipate being surprised by the specific advantages of this cannabinoid that we discover in the ensuing years.
Let’s contrast CBT Cwith a few other cannabinoids to clarify the specific advantages of this substance further:
Chemically speaking, CBT is very similar to CBD. The two cannabinoids also seem to have comparable effects, which makes CBD and CBT a perfect complement—especially in light of the growing influence of CBD.
CBT and CBG (cannabigerol), which are both non-intoxicating cannabinoids, are more alike than unlike. On the cannabinoid family tree, CBT is a few branches away from CBG, the “parent molecule” from which all of the most well-known cannabis compounds originate.
What little we already know suggests that CBT and cannabicyclol (CBL) are pretty comparable. They are both CBC derivatives and don’t make you drunk. However, CBL is created when CBC oxidizes, whereas CBT is created through enzymatic activities.
THC and CBT are not particularly similar. THC is one of the few cannabinoids that has intoxication effects; CBT doesn’t seem to have this characteristic. THC and CBT are also very different from a legislative standpoint because THC is still classified as a Schedule I substance whereas CBT products are normally categorized as cannabis products made from industrial hemp.
It will initially be difficult for products containing CBT to acquire traction once they are available unless they are combined with a chemical that people are already familiar with. In order to do this, we advise combining CBT with either CBD or CBC, with CBD taking the more conventional course and CBC adopting a more novel one.
CBD is now regarded as the gold standard of hemp cannabinoids and is just as reliable as any over-the-counter drug or herbal cure. In light of the fact that CBD and CBT seem to have similar effects, it is the perfect cannabinoid to combine with CBT. Being the most widely used cannabinoid on the market, CBD is offered in a variety of bulk component forms.
Both CBC and CBD are excellent complements to CBT, although for various reasons. Chemically speaking, CBD and CBT may be related, but so are CBT and CBC, and CBC has the appeal of a novel cannabinoid while being more well-known and approachable than CBT. CBC is not intoxicating, like CBT.
When will bulk CBT items be offered for purchase? Three distinct product categories stand out as perfect complements for the special advantages of CBT:
The go-to product in the hemp sector is tinctures. Customers are accustomed to using tinctures, and they rely on this product category to rapidly and effectively provide the advantages of any cannabis.
Tinctures can be made quickly and easily from a wide variety of botanical extracts and oils. Making a tincture into a distinctive “business card” that customers can use to recognize your brand is simple. What better approach to get attention to your brand than to use a novel, intriguing cannabinoid?
Since the beginning of the contemporary hemp market, capsules have been the standard option for hemp users who don’t want to taste their cannabinoids as they ingest them. Although bypassing the sublingual route makes them less accessible than tinctures, it is nevertheless possible to create capsules with a similar variety of chemicals that have the added advantage of not requiring taste. Consumers who are willing to experiment with a new substance but do not want to deal with the inherent complexity of tinctures will find CBT to be more approachable thanks to capsules.
The most delicious hemp goods you can infuse with CBT or any other cannabinoid are gummies, however they aren’t quite as carb-free as capsules or tinctures. Gummies are the most enjoyable and approachable sort of hemp product, making daily dosage of cannabinoids simple and delicious. This helps consumers overcome any reluctance they may have about trying a novel cannabinoid like CBT.
There are several more cannabinoids in development than CBT. Cannabis research up until the last ten years was haphazard and primarily done by the same teams of dispersed Japanese and Israeli academics. We are beginning to see some of the first conclusive findings regarding the cannabis plant and the hundreds of different substances it contains as global cannabis legalization initiatives have grown more coordinated.
In the hemp business, cannabinoids like CBC and CBL that are related to CBT are also becoming more prominent. Think back to the position of CBD in the year 2010. If this all sounds like too much for consumers to keep track of right now, consider that. Nobody could have foreseen at that time that this obscure hemp chemical would become well-known in less than ten years.
Entrepreneurs have always benefited by anticipating these surges in feeling before they reach landfall since the consumer market just requires time to acclimate to new trends. It’s never too early to begin enlightening customers about the impending CBT wave. You can give your consumers a taste of the larger world of hemp that will emerge once CBT products are made available by providing them with related cannabinoids like CBC, which are already widely available.
We offer Wholesale CBT isolates that can be utilized to create unique products. A wide range of consumer health and wellness products can benefit from including this natural component in their formulas.
Cannabigerol is a promising cannabinoid capable of providing a myriad of therapeutic benefits. Scientific studies have indicated that CBG is a potentially potent analgesic, muscle-relaxer,
In recent years, cannabinoids have gained significant attention for their potential therapeutic benefits. While many people are familiar with cannabinoids like THC and CBD, there
You are here:
Our newsletter contains studies on cannabinoids that help you reach your customers
At WeeDutch we gurantee
Commitment to safety and compliant with legal requirements
Premium & consistent quality to ensure optimal effectiveness
Rigorously lab tested cannabinoids and cannabinoid products
Fast Shipping & 14 day money back guarantee
Would you like to receive the brochure about our patented cannabinoid formulas for insomnia, obesity and depression? Fill in your email en receive it direcly!
Would you like to receive the CoA, to ensure the quantity of cannabinoids in this product? Fill in your email en receive it direcly!
